Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials

scientific article published on 02 August 2010

Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJSO.2010.07.001
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0748798310002751?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:S0748798310002751?httpAccept=text/xml
P698PubMed publication ID20674253

P50authorMichael D KlugerQ88961347
P2093author name stringR. N. Taub
Z. Jin
M. Hesdorffer
J. A. Chabot
P2860cites workClassification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a surveyQ30004207
Peritonectomy proceduresQ34316366
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.Q34543902
A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesotheliomaQ36665886
Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancyQ37252011
Consensus statement on peritoneal mesothelioma.Q37252035
Transport of molecules in the tumor interstitium: a reviewQ39768023
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.Q40827609
The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement ProgramQ45334952
Lymph node metastases in diffuse malignant peritoneal mesothelioma.Q46599379
Peritoneal Surface Oncology: A progress reportQ48703661
Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma.Q51798012
Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.Q53593898
Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic PerfusionQ61794224
Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective studyQ64046989
Incidence and descriptive epidemiology of mesothelioma in the United States, 1999-2002Q64127503
Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapyQ67919758
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985Q68250517
Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapyQ69609509
Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesotheliomaQ72709860
Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP)Q73010584
Treatment of primary peritoneal mesothelioma by hyperthemic intraperitoneal chemotherapyQ77781853
Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesotheliomaQ78170268
Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive casesQ79218179
Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesotheliomaQ80980814
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectphase I clinical trialQ5452194
peritoneal mesotheliomaQ7168876
P304page(s)997-1003
P577publication date2010-08-02
P1433published inEuropean Journal of Surgical OncologyQ2345728
P1476titleTwo-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials
P478volume36

Reverse relations

cites work (P2860)
Q34137322Advances in the management of peritoneal mesothelioma
Q37166451Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.
Q58541846Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives
Q37368932Quantitative X-ray computed tomography peritoneography in malignant peritoneal mesothelioma patients receiving intraperitoneal chemotherapy
Q51485434Surgery for peritoneal mesothelioma.

Search more.